Bionano Genomics Inc (NASDAQ:BNGO)
| 1.10 Delayed Data As of Mar 31 |  +0.04 / +3.77%Today’s Change | 1.04 Today|||52-Week Range 4.35 | -24.66% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2016 | 2017 | 2018 | -- | |||
| Operating Activities | Net Income / Starting Line | -18.8M | -23.4M | -18.5M | -- | |
| Depreciation | 1.1M | 1.5M | 1.3M | -- | ||
| Total Other Cash Flow | -2.8M | 958.4K | -399.1K | -- | ||
| Funds From Operations | -20.5M | -20.9M | -17.6M | -- | ||
| Funds From/For Other Operating Expenses | 3.0M | -85.1K | 2.4M | -- | ||
| Net Cash Flow - Operating Activities | -23.5M | -20.8M | -19.9M | -- | ||
| Investing | Capital Expenditures | -1.3M | -1.0M | -331.7K | -- | |
| Net Cash Flow Investing | -1.3M | -1.0M | -331.7K | -- | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | 0.00 | -- | -- |
| Long Term Borrowings | 6.9M | 0.00 | 23.8M | -- | ||
| Long Term Debt Reduction | -5.0M | 0.00 | -7.4M | -- | ||
| Net Proceeds Stock Sale | 23.5M | 17.6M | 19.4M | -- | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | -- | -- | |
| Common Dividends | 0.00 | 0.00 | 0.00 | -- | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | -- | -- | |
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | -- | -- | |
| Other Uses - Financing | 0.00 | 0.00 | 0.00 | -- | -- | |
| Net Cash Flow - Financing | 25.4M | 17.6M | 35.8M | -- | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | -- | -- | -- |
| Net Change In Cash | 584.9K | -4.2M | 15.5M | -- | ||
